Pharmacology, Toxicology and Pharmaceutical Science
Mucosa Inflammation
100%
Chemotherapy
55%
Methotrexate
46%
Microbiome
38%
Intestine Flora
36%
Diarrhea
28%
Citrulline
24%
Microorganism
19%
Malignant Neoplasm
18%
Melphalan
17%
Microflora
17%
High Dose Chemotherapy
15%
Feces microflora
14%
Ascorbic Acid
14%
Injury
13%
Butyrate
12%
Tissue Injury
12%
Bioavailability
12%
Anakinra
12%
Neoplasm
12%
Medium Chain Triacylglycerol
12%
Antibiotics
12%
Riboflavin
12%
Drug Absorption
12%
Antiinfective Agent
11%
Symptom
9%
Lactobacillus
9%
Ciprofloxacin
8%
Folinic Acid
8%
Gastrointestinal Toxicity
7%
Side Effect
6%
Infectious Agent
6%
Wistar Rat
6%
Fluconazole
6%
Intestine Injury
5%
Cytotoxicity
5%
Rat Model
5%
Medicine and Dentistry
Mucositis
48%
Gut Microbiota
23%
Methotrexate
17%
Melphalan
17%
Gut
17%
Diarrhea
15%
Microbiome
15%
High Dose Chemotherapy
15%
Ascorbic Acid
14%
Prophylaxis
14%
Stem Cell Therapy
12%
Experimental Diet
12%
Medium Chain Triacylglycerol
12%
Intestine Mucosa
12%
Interleukin-1
12%
Anakinra
12%
Bioavailability
12%
Tissue Injury
12%
Riboflavin
12%
Drug Absorption
10%
Neoplasm
10%
Malignant Neoplasm
8%
Symptom
8%
Drug Megadose
7%
Antiinfective Agent
7%
Side Effect
6%
Injury
6%
Pathogen
6%
Plasma Citrulline
5%
In Vitro
5%
Intestine Injury
5%
Cytotoxicity
5%
Neutrophil
5%
Keyphrases
Intestinal mucositis
38%
Microbiota
14%
Maintaining Therapy
12%
Anti-infective Drugs
12%
Chemotherapy-induced Diarrhea
12%
Microbiome
12%
Methotrexate
12%
Limit Models
12%
Targeted Intervention
12%
Chemotherapy-induced
12%
Drug Absorption
10%
Acute Fasting
9%
Lactobacillus
9%
Body Composition
9%
Microbial Intervention
7%
Plasma Citrulline
6%
Epithelial Ingrowth
6%
Cancer Patients
6%
Anti-infective
6%
Gut Microbiota
5%
Gastrointestinal
5%
Fecal Swab
5%
Patients with Cancer
5%
